^
Association details:
| Biomarker: | EGFR overexpression |
|---|---|
| Cancer: | Breast Cancer |
| Drug: | Caprelsa (vandetanib) (Multi-tyrosine kinase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Vandetanib as a potential new treatment for estrogen receptor-negative breast cancers
Excerpt:
Vandetanib induced tumor regression in PDX models with high expression of RET or EGFR.
DOI:
10.1002/ijc.29974
